Bio Pharma Dive
FEBRUARY 2, 2023
Though Goldfinch Bio focused on kidney diseases, Karuna believes its experimental drugs may have potential treating psychiatric and neurological conditions
Pharmaceutical Technology
FEBRUARY 7, 2023
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for Takeda ’s dengue virus vaccine candidate, Qdenga (Dengue Tetravalent Vaccine [Live, Attenuated]).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
FEBRUARY 1, 2023
The agency is currently assessing applications filed by the two companies for what they hope will become the first vaccines against the virus in older adults
Pharmaceutical Technology
FEBRUARY 3, 2023
Only a few weeks into the new year, the prospect of getting a successful advanced HIV vaccine shrank after the discontinuation of yet another late-stage trial. On January 18, Janssen, a Johnson & Johnson (J&J) subsidiary, stated that its vaccine was not effective in preventing HIV infections.
Advertiser: FourKites
Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
Pharma Mirror
JANUARY 31, 2023
The Janssen Pharmaceuticals-produced medication Elmiron® is used to treat interstitial cystitis. Elmiron may be connected to eye damage that results in vision loss or other negative effects like blurry vision, according to some studies.
Fierce Pharma
FEBRUARY 3, 2023
J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries mbayer Fri, 02/03/2023 - 09:29
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
FEBRUARY 2, 2023
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline ’s (GSK) Jesduvroq (daprodustat) to treat anaemia caused by chronic kidney disease (CKD) in adults who have been on dialysis for at least four months.
The FDA Law Blog
FEBRUARY 7, 2023
By Adrienne R. Lenz, Principal Medical Device Regulation Expert — For medical device start-up companies, understanding and successfully navigating applicable FDA regulations and requirements is an important part of the path to market.
Fierce Pharma
FEBRUARY 3, 2023
Pressure's on, GSK. Merck's Keytruda drops endometrial cancer win in first-line treatment aliu Fri, 02/03/2023 - 09:43
Pharma Times
FEBRUARY 2, 2023
The central focus of the agreement is to establish peptide hits from selected library populations
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
Bio Pharma Dive
FEBRUARY 2, 2023
The company’s lead drug could be an oral alternative to marketed diabetes and obesity drugs from Novo Nordisk and Eli Lilly
Pharmaceutical Technology
FEBRUARY 3, 2023
The field of genomic medicine has reached a true turning point.
The Pharma Data
FEBRUARY 7, 2023
Fierce Pharma
JANUARY 31, 2023
Pfizer warns Comirnaty sales will plummet by nearly two-thirds in 2023. And Paxlovid won't fare much better kdunleavy Tue, 01/31/2023 - 10:58
Advertiser: Aggregage
The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.
Pharma Times
JANUARY 31, 2023
Phase 3 study demonstrated that efanesoctocog alfa met both primary and secondary endpoints
Bio Pharma Dive
FEBRUARY 2, 2023
The British drugmaker sees potential for the medicine to be a functional cure for chronic infections, and is beginning two Phase 3 trials to test its promise
Pharmaceutical Technology
JANUARY 31, 2023
Gene therapy company uniQure has entered into a global licensing agreement with Apic Bio for APB-102 to treat patients with amyotrophic lateral sclerosis (ALS) caused by mutations in superoxide dismutase 1 (SOD1).
Clairnes
FEBRUARY 7, 2023
The post Maximizing patient recruitment for rhinosinusitis trials in a competitive market appeared first on Clinical Trial Recruitment & Management Services.
Fierce Pharma
FEBRUARY 2, 2023
Novo's Rybelsus comes into its own as Wegovy shakes off supply constraints fkansteiner Thu, 02/02/2023 - 08:57
Pharma Times
FEBRUARY 3, 2023
Partnership involves the study of real-time patient data and identification of adherence issues
Bio Pharma Dive
JANUARY 31, 2023
The pipeline of CAR-T therapies and ex vivo gene therapies has swelled in recent years, but manufacturing hasn’t been able to keep up with demand
Pharmaceutical Technology
FEBRUARY 1, 2023
Pfizer has reported a 30% operational growth in revenues to $100.3bn in full-year 2022 compared with $81.2bn reported last year. The revenues grew 2% operationally excluding Paxlovid and Comirnaty’s contributions.
BioPharma Reporter
JANUARY 31, 2023
UK based, Aptamer Group, and Hong Kong headquartered, BaseCure Therapeutics, are paring up on the development of Optimer-targeted gene therapies. Markets & Regulations
The FDA Law Blog
FEBRUARY 2, 2023
By Mark A. Tobolowsky & Charles G.
Pharma Times
JANUARY 31, 2023
Research concerns ACD440 – a non-opioid drug which treats peripheral neuropathic pain
Bio Pharma Dive
JANUARY 31, 2023
The world’s best-selling drug will face pricing pressure as rivals try to steal share away from AbbVie’s $20 billion-a-year flagship product in the U.S.
Pharmaceutical Technology
FEBRUARY 3, 2023
Merck (MSD outside North America) has reported a 2% increase in worldwide sales to $13.83bn in the fourth quarter (Q4) of 2022 from $13.52bn in the previous year’s quarter. The company’s pharmaceutical sales recorded a 1% rise to $12.18bn compared to $12.03bn in the prior-year quarter.
Roots Analysis
FEBRUARY 6, 2023
Medical Device Coatings – From Supplementary Protection Constituents to Necessary Tools for Various Functions Over the past 50 years, the medical device industry has seen several notable developments.
Pharmaceutical Commerce
FEBRUARY 6, 2023
CDMO is commissioning third GMP biologics facility in Fremont.
Pharma Times
FEBRUARY 1, 2023
Binders will establish cell types and delivery vehicles may increase uptake of the siRNA therapy
Bio Pharma Dive
FEBRUARY 3, 2023
The company, which worked with GSK to develop a coronavirus shot, is ceasing operations after its corporate parent cut off further investment
Pharmaceutical Technology
FEBRUARY 2, 2023
If things go as per plan, in a few months, the US Food and Drug Administration (FDA) will deliberate on the first-of-its-kind CRISPR-based gene therapy for sickle cell disease (SCD) and transfusion-dependent beta thalassemia.
Fierce Pharma
FEBRUARY 1, 2023
Jazz wins reimbursement nod from NICE for cannabinoid med Epidyolex kdunleavy Wed, 02/01/2023 - 10:19
XTalks
FEBRUARY 3, 2023
Loxo Oncology (Eli Lilly and Company) recently announced that their Bruton tyrosine kinase inhibitor (BTKi), Jaypirca (pirtobrutinib), was approved by the US Food and Drug Administration (FDA) to treat adults with relapsed or refractory mantle cell lymphoma (R/R MCL) under the Accelerated Approval pathway.
Expert insights. Personalized for you.
241 
Let's personalize your content